The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 21, 2021

Filed:

Nov. 20, 2018
Applicant:

Embolx, Inc., Sunnyvale, CA (US);

Inventor:

Michael P. Allen, Los Altos, CA (US);

Assignee:

Embolx, Inc., Sunnyvale, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61M 29/00 (2006.01); A61M 31/00 (2006.01); A61M 37/00 (2006.01); A61M 5/168 (2006.01); A61B 17/12 (2006.01); A61M 5/172 (2006.01); A61M 25/00 (2006.01); A61M 25/10 (2013.01);
U.S. Cl.
CPC ...
A61M 5/16804 (2013.01); A61B 17/12 (2013.01); A61B 17/1204 (2013.01); A61M 5/172 (2013.01); A61M 5/1723 (2013.01); A61M 25/00 (2013.01); A61M 25/0068 (2013.01); A61M 25/0069 (2013.01); A61M 25/0075 (2013.01); A61M 25/10 (2013.01); A61M 25/1025 (2013.01); A61B 17/12109 (2013.01); A61B 17/12136 (2013.01); A61M 25/1002 (2013.01); A61M 2005/1726 (2013.01); A61M 2025/0001 (2013.01); A61M 2025/0002 (2013.01); A61M 2025/0003 (2013.01); A61M 2025/0076 (2013.01); A61M 2025/105 (2013.01); A61M 2025/109 (2013.01); A61M 2025/1052 (2013.01); A61M 2025/1061 (2013.01); A61M 2025/1081 (2013.01); A61M 2025/1093 (2013.01); A61M 2025/1097 (2013.01); A61M 2210/12 (2013.01);
Abstract

A method of embolizing a tumor includes advancing a distal end of a device having a catheter body and an occlusion structure to a target tumor site within a blood vessel of a body. The occlusion structure is activated within the blood vessel, and a real time pressure measurement in the vascular space distal to the activated occlusion structure is monitored. The method further includes waiting for a pressure drop in the vascular space distal to the activated occlusion structure and for the pressure drop to cause a blood flow reversal in branch vessels antegrade to the occlusion. An embolic substance is injected from the distal end of the delivery device to permit the reversed blood flow to carry the embolic substance into the vasculature of the target tumor and the device is withdrawn from the body. Other catheter assemblies and methods of use are also disclosed.


Find Patent Forward Citations

Loading…